[Federal Register Volume 64, Number 101 (Wednesday, May 26, 1999)]
[Notices]
[Pages 28493-28497]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-13332]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention
[Program Announcement 99134]


Cooperative Agreement for Surveillance of Intimate Partner 
Violence; Notice of Availability of Funds

A. Purpose

    The Centers for Disease Control and Prevention (CDC) announces the 
availability of fiscal year (FY) 1999 funds for a cooperative agreement 
program for Surveillance of Intimate Partner Violence (IPV). This 
program addresses the ``Healthy People 2000'' priority area of Violent 
and Abusive Behavior. The purpose of the program is to develop IPV 
population-based surveillance systems that will help determine the 
magnitude of the IPV problem in population subgroups, and test its 
usefulness by comparing resulting data with data from self-report 
surveys.

B. Eligible Applicants

    Assistance will be provided only to the health departments of 
States or their bona fide agents, including the District of Columbia, 
the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth 
of the Northern Mariana Islands, American Samoa, Guam, federally 
recognized Indian tribal governments, the Federated States of 
Micronesia, the Republic of the Marshall Islands, and the Republic of 
Palau. In consultation with States, assistance may be provided to 
political subdivisions of States.
    Massachusetts, Michigan, and Rhode Island, States currently 
receiving funds under Announcement No. 483, ``State Injury Intervention 
Programs,'' are not eligible to apply for this announcement.

C. Availability of Funds

    Approximately $600,000 is available in FY 1999 to fund 
approximately two awards. It is expected that the average award will be 
$300,000. Ranging from

[[Page 28494]]

$250,000 to $300,000. It is expected that the awards will begin on or 
about September 30, 1999, and will be made for a 12-month budget period 
within a project period of up to five years. Funding estimates may 
change.
    Continuation awards within an approved project period will be made 
on the basis of satisfactory progress as evidenced by required reports 
and the availability of funds.

D. Funding Preferences

    Preference will be given to those applicants that have jurisdiction 
over urban areas with a population equal or more than one million. A 
population of one million or more will provide a large sample size that 
will allow generalization of the design and methodology of developed 
IPV Surveillance Systems.

E. Program Requirements

    In conducting activities to achieve the purpose of this program, 
the recipient will be responsible for the activities under 1. 
(Recipient Activities), and CDC will be responsible for the activities 
listed under 2. (CDC Activities).

1. Recipient Activities

    a. Develop or enhance existing injury surveillance activities to 
support IPV surveillance to identify victims and occurrences of IPV, 
including data describing the magnitude of the problem and the extent 
of injuries (i.e., who is affected, areas and persons at greatest risk, 
and the type and source of the information used).
    b. Establish a surveillance system, or enhance an existing 
surveillance system, capable of linking with one or more health-related 
data sources to determine intimate partner violence incidence and 
prevalence in the targeted area (e.g., linkage of emergency departments 
or hospital discharge data with mental health data).
    c. Enhance the capacity of the applicant for general injury 
surveillance by incorporating the IPV surveillance system with other 
existing injury surveillance systems.
    d. Design, develop, and implement a health-related surveillance 
system to measure intimate partner violence and field test CDC's 
Uniform Definitions and Recommended Data Elements for IPV Surveillance 
if no surveillance system is in place, or expand currently existing 
surveillance system to incorporate health-related data and field test 
the CDC's Uniform Definitions and Recommended Data Elements for IPV 
Surveillance.
    e. Design, develop and conduct a self-report survey using the same 
population where the surveillance activities will be conducted.
    f. Establish and maintain cooperative partnerships with key 
personnel of potential data source agencies (e.g., hospitals, emergency 
departments, etc.).
    g. Monitor quality, representativeness and completeness of 
surveillance data.
    h. Collect and analyze surveillance data.
    i. Produce and distribute periodic progress reports and data 
summaries to appropriate state and local agencies and, develop 
replication guidelines for future use by other states and localities.
    j. Establish an advisory committee to exchange information and 
increase the likelihood of integrated injury surveillance systems.

2. CDC Activities

    a. Provide technical assistance in the design of all phases of the 
IPV surveillance programs, including consultation on data collection 
instruments and procedures.
    b. Provide technical assistance in developing a standardized 
approach to surveillance and evaluation activities between and among 
each of the project areas.
    c. Provide consultation and assistance in problem assessment and 
target population identification, the evaluation of coverage, cost, and 
impact of surveillance activities, and design of scientific protocols.
    d. Provide consultation on survey designs and IPV surveillance 
systems for State implementation.
    e. Collaborate in the analysis and dissemination of IPV 
surveillance data.
    f. Provide up-to-date scientific information about intimate partner 
violence and coordinate related activities at CDC's National Center for 
Injury Prevention and Control.
    g. Assist in the transfer of information and methods developed in 
this program to other geographical areas.
    h. Assist in the development of a research protocol for IRB review 
by all cooperating institutions participating in the research project. 
The CDC IRB will review and approve the protocol initially and on at 
least an annual basis until the research project is completed.

F. Application Content

    Use the information in the Program Requirements, Other 
Requirements, and Evaluation Criteria sections to develop the 
application content. Your application will be evaluated on the criteria 
listed, so it is important to follow them in laying out your program 
plan. The narrative should be no more than 45 double-spaced pages, 
printed on one side, with one inch margins, and unreduced font.

1. Abstract

    A one double-spaced page abstract and summary of the proposed 
intimate partner violence surveillance system and self-report survey is 
required.

2. Background and Need

    a. The applicant should describe and document the magnitude of the 
intimate partner violence problem in the applicant's targeted area, and 
provide a profile of the persons and groups at greatest risk.
    b. The applicant should include a description of its current 
activities and previous experiences in intimate partner violence 
surveillance, evaluation, and coordination with other agencies and 
potential partners.
    c. The applicant should include an assessment of existing injury 
surveillance capacity.
    d. All information described in this section must be referenced.

3. Goals

    a. The applicant should include specific goals which indicate where 
the applicant anticipates its intimate partner violence surveillance 
program will be at the end of the five year project period.
    b. The applicant should include a description of and evidence of 
its willingness and ability to undertake related projects should 
additional funds become available.

4. Objectives

    a. The applicant should include specific time-phased, measurable, 
and achievable objectives during the first budget period.
    b. The applicant's objectives should relate directly to the project 
goals, and include, but not be limited to, use of various health-
related information sources, effort to achieve representativeness, 
surveillance system evaluation, collaboration, and demonstrate the 
utility of the surveillance system and self-report survey in 
replication efforts.

5. Methodology

    a. The applicant should also include a detailed description of 
specific activities that are proposed to achieve each of the program 
objectives during the budget period. Activities should also include 
design, development, and administration of a self-report survey for the 
same population where the surveillance is conducted. Activities should 
also include how often the self-report survey will be conducted and how 
will the survey be incorporated as an integral part of the IPV 
Surveillance System.

[[Page 28495]]

    b. The applicant should include a detailed time-line which 
indicates when each activity and preparations for activities will 
occur. For each activity, describe who will do what to implement the 
activities. Specifically provide a description of potential data 
sources, how these will be accessed, and how some may be linked. If 
other units or organizations will collaborate, describe the role of the 
unit or organization, who will be responsible for the designated 
activities, and explicitly explain how these organizations will deal 
with privacy and confidentiality issues (e.g., encryption, security, 
etc.). Document concurrences with this plan by other units or 
organizations that are collaborating with the applicant.
    c. The applicant should include an organization chart identifying 
placement of the intimate partner violence surveillance program within 
organizational units with existing jurisdiction and authority over 
other injury surveillance systems. The organization chart should also 
include collaborating components and their relationship to the intimate 
partner violence surveillance program.
    d. The applicant should include a detailed description of the 
procedures that makes the applicant compliant with CDC's Policy 
requirements regarding the inclusion of women, ethnic, and racial 
groups in the proposed research. The applicant's procedures should 
include:
    (1) A proposed plan for the inclusion of both sexes and racial and 
ethnic minority populations for appropriate representation.
    (2) The proposed justification when representation is limited or 
absent.
    (3) A statement as to whether the design of the study is adequate 
to measure differences when warranted.
    (4) A statement as to whether the plans for recruitment and 
outreach for study participants include the process of establishing 
partnerships with community(ies) and recognition of mutual benefits.

6. Evaluation Plan

    a. The applicant should include a detailed description of the 
methods and design to be used to evaluate the IPV surveillance system, 
including what will be evaluated, data to be used, who will perform the 
evaluation and the time it will take (timeline) to do the evaluation. 
Specifically address the sensitivity, usefulness, simplicity, 
flexibility, acceptability, timeliness, representativeness, predictive 
value positive, and cost.
    b. The applicant should document staff availability, expertise, and 
capacity to evaluate surveillance activities. The evaluation should 
include development of tools and data set structures that will enable 
the IPV surveillance system, design of self-report survey instruments, 
and other relevant activities such as, training of hospital staff to 
identify and collect IPV data, and evaluation of software applications 
and computer equipment. The evaluation should also include progress in 
meeting the objectives and conducting activities during the budget and 
project periods.

7. Coordination and Collaboration

    a. The applicant should include a description of the relationship 
between the program and other organizations, agencies, and health 
department units that will relate to the program, or which conduct 
related activities. Include composition and roles of any state and/or 
local coalitions involved with the applicant in developing the IPV 
surveillance system and self-report survey; specific commitments of 
support to provide staff, equipment, space, time, etc.
    b. The applicant should include a description of any proposed 
collaboration with academic institutions, public safety officials, or 
with other agencies should be included. In addition, a description of 
the responsibilities and composition of the surveillance advisory 
committee should be included in this section.

8. Project Management and Staffing

    a. The applicant should include a description of the roles and 
responsibilities of the project director, epidemiologist, and each 
staff member, including a description of staff with appreciable 
experience in other injury surveillance systems expected to work in the 
IPV Surveillance System.
    b. The applicant should describe the allocation of staff to the 
activities described in the Methodology section. Descriptions should 
include the position titles, education and experience required, and the 
percentage of time each will devote to the program. In addition, the 
description should also state the methods the staff will employ to 
train others to collect and manage IPV data. Curriculum vitae for 
existing staff should also be included.
    c. In an appendix, the applicant should provide a letter from each 
collaborating consultant or outside agency described in the Methodology 
section. The letter should state their willingness and ability to 
fulfill the proposed responsibilities.

9. Budget

    The applicant should provide a detailed first budget with 
accompanying narrative justifying all individual budget items which 
make up the total amount of funds requested. The budget should be 
consistent with stated objectives and planned activities.

10. Human Subjects

    a. The applicant should describe the degree to which human subjects 
may be at risk and what protections will be in place to assure 
protections and confidentiality.
    b. The applicant should demonstrate that it has adequately 
addressed the requirements of Title 45 CFR Part 46 for the protection 
of human subjects.

G. Submission and Deadline

    Submit the original and two copies of PHS 5161-1 (OMB Number 0937-
0189). Forms are in the application kit.
    On or before July 19, 1999, submit the application to the Grants 
Management Specialist identified in the ``Where To Obtain Additional 
Information'' section of this announcement.

1. Deadline

    Applications shall be considered as meeting the deadline if they 
are either:
    (a) Received on or before the deadline date; or
    (b) Sent on or before the deadline date and received in time for 
orderly processing. (Applicants must request a legibly dated U.S. 
Postal Service postmark or obtain a legibly dated receipt from a 
commercial carrier or U.S. Postal Service. Private metered postmarks 
shall not be acceptable as proof of timely mailing.)

2. Late Applications

    Applications which do not meet the criteria in (a) or (b) above are 
considered late applications, will not be considered, and will be 
returned to the applicant.

H. Evaluation Criteria

    Each application will be evaluated individually against the 
following criteria by an independent review group appointed by CDC.

1. Background and Need (10 points)

    a. The extent to which the applicant documents the magnitude of the 
intimate partner violence problem in the applicant's targeted area, and 
provides a profile of the persons and groups at greatest risk.
    b. The extent to which the applicant documents its current 
activities and previous experiences in intimate partner violence 
surveillance, evaluation, and coordination with other agencies and 
potential partners.

[[Page 28496]]

    c. The extent to which the applicant has made a complete assessment 
of existing injury surveillance capacity.

2. Goals (15 points)

    a. The extent to which the applicant states specific goals that 
indicate where the applicant anticipates its intimate partner violence 
surveillance program will be at the end of the five year project 
period.
    b. The extent to which the applicant describes and provides 
evidence of its willingness and ability to undertake related projects 
should additional funds become available.

3. Objectives (15 points)

    a. The extent to which the applicant states specific, time-phased, 
measurable and achievable objectives.
    b. The extent to which the applicant relates the objectives 
directly to the project goals and the use of various health-related 
information sources, effort to achieve representativeness, surveillance 
system evaluation, collaboration, and demonstrates the utility of the 
surveillance system and self-report survey in replication efforts.

4. Methodology (15 points)

    a. The extent to which the applicant describes specific activities 
that are proposed to achieve each of the program objectives during the 
budget period.
    b. The extent to which the applicant provides a time-line which 
indicates when each activity and preparations for activities will 
occur.
    c. The extent to which the applicant provides evidence of an 
organizational chart that represents the actual structure of the 
proposed IPV surveillance operating organization and its placement in 
organizational units with existing jurisdiction and authority over 
other injury surveillance systems.
    d. The extent to which the applicant provides evidence it has met 
the CDC Policy requirements regarding the inclusion of women, ethnic, 
and racial groups in the proposed research.

5. Evaluation Plan (15 points)

    a. The extent to which the applicant describes the methods and 
design to be used to evaluate the IPV surveillance system, including 
what will be evaluated, data to be used, who will perform the 
evaluation and the time it will take (timeline) to do the evaluation.
    b. The extent to which the applicant provides evidence of staff 
availability, expertise, and capacity to evaluate surveillance 
activities.

6. Coordination and Collaboration (15 points)

    a. The extent to which the applicant describes the relationship 
between the program and other organizations, agencies, and health 
department units that will relate to the program or which conduct 
related activities.
    b. The extent to which applicant provides evidence of collaboration 
with academic institutions, public safety officials, or with other 
agencies. In addition, the extent to which the applicant describes 
responsibilities and composition of the surveillance advisory 
committee.

7. Project Management and Staffing (15 points)

    a. The extent to which the applicant documents the experience in 
the management of intimate partner violence surveillance, and describes 
the roles and responsibilities of the project director, epidemiologist, 
and each staff member, including a description of staff with 
appreciable experience in other injury surveillance systems expected to 
work in the IPV Surveillance System.
    b. The extent to which the applicant includes letters in the 
appendix from each collaborating consultant or outside agency stating 
their willingness and ability to fulfill the proposed responsibilities.

8. Budget (Not scored)

    The extent to which the budget request is clearly explained, 
adequately justified, reasonable, sufficient, and consistent with the 
stated objectives and planned activities.

9. Human Subjects (Not scored)

    a. The extent to which the applicant describes the degree to which 
human subjects may be at risk.
    b. The extent to which the applicant provides assurances that all 
activities will conform to the requirements of 45 CFR, part 46.

I. Other Requirements

    Technical Reporting Requirements:
    Provide CDC with original plus two copies of
    1. Progress reports (semiannual);
    2. Financial status report, no more than 90 days after the end of 
the budget period; and
    3. Final financial and performance reports, no more than 90 days 
after the end of the project period.
    Send all reports to the Grants Management Specialist identified in 
the ``Where to Obtain Additional Information'' section of this 
announcement.
    The following additional requirements are applicable to this 
program. For a complete description of each, see Addendum in the 
application package.

AR-1  Human Subjects Requirements
AR-2  Requirements for Inclusion of Women and Racial and Ethnic 
Minorities in Research
AR-7  Executive Order 12372 Review
AR-9  Paperwork Reduction Act Requirements
AR-10  Smoke-Free Workplace Requirements
AR-11  Healthy People 2000
AR-12  Lobbying Restrictions
AR-13  Prohibition on Use of CDC Funds for Certain Gun Control 
Activities

J. Authority and Catalog of Federal Domestic Assistance Number

    This program is authorized under sections 301, 317k(2), and 391-394 
of the Public Health Service Act, [42 U.S.C. 241, 247b(k)(2), and 280-
280b-2], as amended. The Catalog of Federal Domestic Assistance number 
is 93.136.

K. Where To Obtain Additional Information

    This and all other CDC Announcements may be found and downloaded 
from the CDC homepage. Internet address: http://www.cdc.gov (click on 
funding).
    To receive additional written information and to request an 
application kit, call 1-888-GRANTS4 (1-888-472-6874). You will be asked 
to leave your name and address and will be instructed to identify the 
Announcement number of Interest.
    If you have questions after reviewing the contents of all the 
documents, business management technical assistance may be obtained 
from:
    Ricky Willis, Grants Management Specialist, Grants Management 
Branch, Procurement and Grants Office, Announcement 99134, Centers for 
Disease Control and Prevention, 2920 Brandywine Road, Suite 3000, 
Mailstop E-13, Atlanta, GA 30341-4146, Telephone: (770) 488-2719, E-
mail address: [email protected]
    For program technical assistance contact: Enrique Nieves, Project 
Officer, National Center for Injury Prevention and Control, Centers for 
Disease Control and Prevention, 4770 Buford Highway, N.E., Mailstop K-
63, Atlanta, GA 30341, Telephone: (770) 488-1281, E-mail address: 
[email protected]


[[Page 28497]]


    Dated: May 20, 1999.
John L. Williams,
Director, Procurement and Grants Office, Centers for Disease Control 
and Prevention (CDC).
[FR Doc. 99-13332 Filed 5-25-99; 8:45 am]
BILLING CODE 4163-18-P